{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:29:52Z","timestamp":1788564592127,"version":"build-2803163510"},"reference-count":37,"publisher":"Microbiology Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,5,1]]},"abstract":"<jats:p>The WHO smallpox eradication program was concluded 21 years ago and the non-vaccinated population is now at risk of poxvirus infections, either by contact with monkeypox or through bioterrorism. Since drugs specific against poxvirus infections are limited, neutralizing monoclonal antibodies (mAbs) that are effective<jats:italic>in vivo<\/jats:italic>may be an important tool in controlling poxvirus infections. To this end, we studied the efficacy of the mAb C3, reactive against the trimeric 14-kDa protein of vaccinia virus (VV) localized in the membrane of the intracellular form of mature virus, for its ability to neutralize VV infection in mice. The results show that prophylactic as well as therapeutic administration of mAb C3 can be an effective means of control of VV replication within the host. The interval of antibody efficacy following a single administration, before and after VV inoculation, has been defined. This study reinforces the notion that neutralizing mAbs should be developed to control health-related human infections by poxviruses.<\/jats:p>","DOI":"10.1099\/0022-1317-83-5-1059","type":"journal-article","created":{"date-parts":[[2015,8,26]],"date-time":"2015-08-26T14:48:30Z","timestamp":1440600510000},"page":"1059-1067","source":"Crossref","is-referenced-by-count":58,"title":["Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions"],"prefix":"10.1099","volume":"83","author":[{"given":"Juan C.","family":"Ram\u00edrez","sequence":"first","affiliation":[{"name":"Department of Molecular and Cellular Biology, Centro Nacional de Biotecnolog\u00eda, CSIC, Campus Universidad Aut\u00f3noma, E-28049 Madrid, Spain1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Tapia","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology, Centro Nacional de Biotecnolog\u00eda, CSIC, Campus Universidad Aut\u00f3noma, E-28049 Madrid, Spain1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Esteban","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology, Centro Nacional de Biotecnolog\u00eda, CSIC, Campus Universidad Aut\u00f3noma, E-28049 Madrid, Spain1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1099\/0022-1317-23-2-197","article-title":"Neutralizing activities of antisera to poxvirus soluble antigens","volume":"23","author":"Appleyard","year":"1974","journal-title":"Journal of General Virology"},{"key":"R2","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1128\/JVI.66.7.4170-4179.1992","article-title":"Role of cell-associated enveloped vaccinia virus in cell-to-cell spread","volume":"66","author":"Blasco","year":"1992","journal-title":"Journal of Virology"},{"key":"R3","first-page":"86","article-title":"Differences between extracellular and intracellular forms of poxvirus and their implications","volume":"16","author":"Boulter","year":"1973","journal-title":"Progress in Medical Virology"},{"key":"R4","first-page":"45","article-title":"Monkeypox: an emerging infection for humans?","volume-title":"In Emerging Infections","author":"Breman","year":"2000"},{"key":"R5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199808203390811","article-title":"Poxvirus dilemmas \u2013 monkeypox, smallpox, and biologic terrorism","volume":"339","author":"Breman","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"R6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/MR.55.1.80-122.1991","article-title":"Poxvirus pathogenesis","volume":"55","author":"Buller","year":"1991","journal-title":"Microbiological Reviews"},{"key":"R7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/317813a0","article-title":"Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype","volume":"317","author":"Buller","year":"1985","journal-title":"Nature"},{"key":"R8","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1099\/0022-1317-71-10-2341","article-title":"Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies","volume":"71","author":"Czerny","year":"1990","journal-title":"Journal of General Virology"},{"key":"R9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0042-6822(87)90481-8","article-title":"A 14K envelope protein of vaccinia virus with an important role in virus-host cell interactions is altered during virus persistence and determines the plaque size phenotype of the virus","volume":"159","author":"Dallo","year":"1987","journal-title":"Virology"},{"key":"R10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"key":"R11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0042-6822(90)90381-Z","article-title":"Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein","volume":"178","author":"Gong","year":"1990","journal-title":"Virology"},{"key":"R12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0042-6822(91)90901-M","article-title":"A prominent antigenic surface polypeptide involved in the biogenesis and function of the vaccinia virus envelope","volume":"181","author":"Gordon","year":"1991","journal-title":"Virology"},{"key":"R13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/JVI.55.3.651-659.1985","article-title":"Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment","volume":"55","author":"Hiller","year":"1985","journal-title":"Journal of Virology"},{"key":"R14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"key":"R15","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"Journal of Virology"},{"key":"R16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1006\/viro.1996.0142","article-title":"Extracellular enveloped vaccinia virus escapes neutralization","volume":"217","author":"Ichihashi","year":"1996","journal-title":"Virology"},{"key":"R17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1542\/peds.26.2.176","article-title":"Studies on smallpox and complications of smallpox vaccination","volume":"20","author":"Kempe","year":"1960","journal-title":"Pediatrics"},{"key":"R18","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1128\/JVI.65.10.5631-5635.1991","article-title":"The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals","volume":"65","author":"Lai","year":"1991","journal-title":"Journal of Virology"},{"key":"R19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.2000.0750","article-title":"Antibody neutralization of the extracellular enveloped form of vaccinia virus","volume":"280","author":"Law","year":"2001","journal-title":"Virology"},{"key":"R20","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1073\/pnas.93.21.11341","article-title":"Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety","volume":"93","author":"Moss","year":"1996","journal-title":"Proceedings of the National Academy of Sciences, USA"},{"key":"R21","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(05)63725-7","article-title":"Re-emergence of human monkeypox in Zaire in 1996","volume":"349","author":"Mukinda","year":"1997","journal-title":"Lancet"},{"key":"R22","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JVI.74.2.923-933.2000","article-title":"Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine","volume":"74","author":"Ram\u00edrez","year":"2000","journal-title":"Journal of Virology"},{"key":"R23","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1093\/nar\/18.18.5347","article-title":"IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress","volume":"18","author":"Rodr\u00edguez","year":"1990","journal-title":"Nucleic Acids Research"},{"key":"R24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/JVI.56.2.482-488.1985","article-title":"Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus","volume":"56","author":"Rodr\u00edguez","year":"1985","journal-title":"Journal of Virology"},{"key":"R25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1128\/JVI.61.2.395-404.1987","article-title":"A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers","volume":"61","author":"Rodr\u00edguez","year":"1987","journal-title":"Journal of Virology"},{"key":"R26","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1073\/pnas.85.5.1667","article-title":"Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals","volume":"85","author":"Rodr\u00edguez","year":"1988","journal-title":"Proceedings of the National Academy of Sciences, USA"},{"key":"R27","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JVI.67.6.3435-3440.1993","article-title":"The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene","volume":"67","author":"Rodr\u00edguez","year":"1993","journal-title":"Journal of Virology"},{"key":"R28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0168-1702(94)00113-Q","article-title":"Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola viruses","volume":"36","author":"Shchelkunov","year":"1995","journal-title":"Virus Research"},{"key":"R29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-4615-5331-1_51","article-title":"Extracellular enveloped vaccinia virus. Entry, egress, and evasion","volume":"440","author":"Smith","year":"1998","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"R30","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1128\/JVI.69.6.3560-3574.1995","article-title":"Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus","volume":"69","author":"Sodeik","year":"1995","journal-title":"Journal of Virology"},{"key":"R31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1099\/0022-1317-13-1-19","article-title":"Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus","volume":"13","author":"Turner","year":"1971","journal-title":"Journal of General Virology"},{"key":"R32","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1099\/0022-1317-78-8-2041","article-title":"Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation","volume":"78","author":"Vanderplasschen","year":"1997","journal-title":"Journal of General Virology"},{"key":"R33","doi-asserted-by":"crossref","first-page":"9098","DOI":"10.1128\/JVI.73.11.9098-9109.1999","article-title":"Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus","volume":"73","author":"V\u00e1zquez","year":"1999","journal-title":"Journal of Virology"},{"key":"R34","doi-asserted-by":"crossref","first-page":"10126","DOI":"10.1128\/JVI.72.12.10126-10137.1998","article-title":"The vaccinia virus 14-kilodalton (A27L) fusion protein forms a triple coiled-coil structure and interacts with the 21-kilodalton (A17L) virus membrane protein through a C-terminal \u03b1-helix","volume":"72","author":"V\u00e1zquez","year":"1998","journal-title":"Journal of Virology"},{"issue":"4","key":"R35","article-title":"The Global Eradication of Smallpox. Final Report of the Global Commission for the Certification of Smallpox Eradication","volume":"no","year":"1980","journal-title":"History of International Public Health"},{"key":"R36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"key":"R37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-065X.1997.tb00969.x","article-title":"Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity","volume":"156","author":"Zinkernagel","year":"1997","journal-title":"Immunological Reviews"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/0022-1317-83-5-1059?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T23:22:53Z","timestamp":1653088973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/0022-1317-83-5-1059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,1]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5,1]]}},"URL":"https:\/\/doi.org\/10.1099\/0022-1317-83-5-1059","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5,1]]}}}